P2D Bioscience’s lead compounds, PD2005 and PD2007, have received U.S. and Canadian patent protection for treating Attention Deficit/Hyperactivity Disorder (ADHD). The patents contain ADHD-use claims for the entire family of P2D’s first-in-class dopamine transport inhibitors, including PD2005 and PD2007. Click here to read entire release Tweet
P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder (ADHD) stimulant drug, PD2005, demonstrated efficacy in treating the core symptoms of ADHD in preclinical ADHD models. The independently conducted studies were funded by a grant from the National Institutes of Health (NIH). Click here to read the entire […]
The Bee is Online Invoicing, Time and Expense Tracking, and Profit Reporting for Freelancers, Contractors, Solopreneurs and Other Service Providers B2Bee, an online Invoicing, Time and Expense tracking, and Profit reporting tool for freelancers, contractors, soloproeneurs and other service providers, has added Time Tracking to its application. B2Bee customers can now enter time for hourly services or […]
Adventure, Challenging Puzzles and a Sinister Plot Wrapped in Brilliant HD Graphics Await Gamers of All Ages aideMMedia, a European game and entertainment icon with more than 1 million games sold, has launched its next flagship game, “City of Secrets,” a classical, point-and-click mystery adventure game developed for the iPad, Mac, iPhone and iPod Touch. The […]
TeamDynamixHE and Customers to Share Best Practices, Innovative Approaches and Growing Role of PPM in Higher Education Success In an effort to navigate shrinking budgets, higher education institutions across the United States are leveraging project and portfolio management (PPM) processes and applications to improve project planning, prioritization and success. It is with this focus that […]
